avrg: SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Name | miRBASE accession |
---|---|
hsa-miR-15a-5p
|
MIMAT0000068 |
hsa-miR-15b-5p
|
MIMAT0000417 |
hsa-miR-16-5p
|
MIMAT0000069 |
hsa-miR-195-5p
|
MIMAT0000461 |
hsa-miR-424-5p
|
MIMAT0001341 |
hsa-miR-497-5p
|
MIMAT0002820 |
hsa-miR-6838-5p
|
MIMAT0027578 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 3.8 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.7 | 2.0 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.6 | 1.8 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
0.6 | 1.7 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.6 | 1.7 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.5 | 1.6 | GO:0021503 | neural fold bending(GO:0021503) |
0.5 | 1.5 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.5 | 1.4 | GO:0002188 | translation reinitiation(GO:0002188) |
0.4 | 1.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.4 | 1.1 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.3 | 1.3 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.3 | 1.0 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.3 | 1.0 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) renal vesicle induction(GO:0072034) regulation of testosterone biosynthetic process(GO:2000224) |
0.3 | 1.3 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
0.3 | 2.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 0.9 | GO:1903572 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.3 | 0.9 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.3 | 0.9 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.3 | 0.8 | GO:0048633 | negative regulation of auditory receptor cell differentiation(GO:0045608) positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.3 | 1.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.3 | 1.1 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.3 | 0.3 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.3 | 1.0 | GO:0035978 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
0.3 | 0.3 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
0.3 | 0.8 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.2 | 1.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 4.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 0.4 | GO:2001038 | regulation of cellular response to drug(GO:2001038) |
0.2 | 4.9 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.2 | 0.8 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.2 | 0.6 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.2 | 0.6 | GO:0007538 | primary sex determination(GO:0007538) |
0.2 | 3.1 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 0.6 | GO:0031106 | septin ring assembly(GO:0000921) septin ring organization(GO:0031106) |
0.2 | 0.6 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.2 | 0.9 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 0.7 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.2 | 0.5 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
0.2 | 1.2 | GO:0051012 | microtubule sliding(GO:0051012) |
0.2 | 0.5 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.2 | 0.5 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.2 | 0.5 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 2.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.7 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.1 | 0.4 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
0.1 | 0.9 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.9 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 3.1 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 1.4 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.6 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.1 | 0.4 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.1 | 0.8 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.1 | 0.5 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.1 | 0.8 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.1 | 0.7 | GO:0018032 | protein amidation(GO:0018032) |
0.1 | 0.4 | GO:0071504 | cellular response to heparin(GO:0071504) |
0.1 | 0.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 1.3 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.9 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.9 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 1.3 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.1 | 0.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.1 | 0.8 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 1.4 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.7 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.3 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.1 | 0.3 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.1 | 0.8 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 1.0 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 1.6 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 3.3 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.5 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 2.5 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.5 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.1 | 0.6 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.1 | 0.3 | GO:1904978 | regulation of endosome organization(GO:1904978) |
0.1 | 0.4 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.1 | 0.6 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.1 | 0.4 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.1 | 1.0 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 1.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.3 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 3.3 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.1 | 0.6 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
0.1 | 0.1 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.1 | 0.4 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.6 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 1.7 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.1 | 0.2 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.1 | 1.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.3 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
0.1 | 0.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 1.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.3 | GO:0089709 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
0.1 | 0.8 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.6 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 1.0 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.1 | 0.2 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.1 | 1.0 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.1 | 0.3 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.1 | 0.7 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 0.5 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.1 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.8 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.7 | GO:0051044 | cleavage furrow formation(GO:0036089) positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.1 | 0.3 | GO:0051029 | rRNA transport(GO:0051029) |
0.1 | 0.4 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.1 | 0.4 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.1 | 0.3 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.2 | GO:0019085 | early viral transcription(GO:0019085) |
0.1 | 1.2 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.2 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.1 | 0.5 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.0 | 0.2 | GO:0044010 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
0.0 | 0.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 1.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.7 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.2 | GO:0051413 | response to cortisone(GO:0051413) |
0.0 | 0.2 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.0 | 2.0 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.0 | 0.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.6 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.6 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.0 | 1.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 1.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.4 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.6 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.3 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.2 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.0 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.9 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.0 | 0.6 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.2 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.0 | 0.3 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.0 | 0.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) response to interleukin-15(GO:0070672) |
0.0 | 0.8 | GO:0086016 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
0.0 | 0.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.6 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.0 | 0.1 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.0 | 0.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 1.0 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.7 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.2 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.0 | 0.3 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.6 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.0 | 0.3 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.0 | 0.5 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.1 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.0 | 0.1 | GO:0018283 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
0.0 | 1.4 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 2.7 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 0.4 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.0 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
0.0 | 0.7 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.5 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.4 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 1.5 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.3 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.5 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.7 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.0 | 1.1 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 1.6 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 1.0 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 1.0 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
0.0 | 0.5 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.9 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.3 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.0 | 0.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.4 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.1 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.0 | 0.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.9 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 1.0 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.5 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 0.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 1.1 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.4 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 | 0.5 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.2 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.0 | 0.1 | GO:1900276 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.0 | 1.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.0 | 0.9 | GO:1902592 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.0 | 3.6 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.1 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.0 | 0.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.0 | 0.3 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.0 | 0.3 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 0.4 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.0 | 3.1 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 1.5 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.0 | 0.1 | GO:0001878 | response to yeast(GO:0001878) |
0.0 | 0.5 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.4 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.0 | 0.1 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.0 | 0.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.0 | 0.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.5 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.0 | 0.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 1.0 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 1.8 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.0 | 0.7 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.0 | 0.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.4 | GO:0040013 | negative regulation of locomotion(GO:0040013) |
0.0 | 0.3 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.3 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.1 | GO:0071484 | cellular response to light intensity(GO:0071484) |
0.0 | 0.1 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.0 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.0 | 0.3 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.0 | 1.1 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.0 | 1.9 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.8 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.0 | 0.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.2 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 1.3 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.0 | 0.3 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.0 | 0.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.0 | 0.2 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.0 | 0.1 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.0 | 0.5 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.3 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 2.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 1.2 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.0 | 0.4 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.0 | 0.0 | GO:1904647 | response to rotenone(GO:1904647) |
0.0 | 0.4 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 | 0.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.2 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.0 | 0.2 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.0 | 0.0 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.3 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.0 | 0.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.4 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 0.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.4 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 4.6 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.5 | 0.5 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.5 | 1.4 | GO:0043614 | multi-eIF complex(GO:0043614) |
0.4 | 1.2 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.4 | 2.0 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 1.7 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.2 | 0.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 0.7 | GO:0031213 | RSF complex(GO:0031213) |
0.2 | 0.8 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.2 | 1.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 2.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.7 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.4 | GO:0031592 | centrosomal corona(GO:0031592) |
0.1 | 1.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 1.0 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.1 | 0.4 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.1 | 0.3 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.1 | 1.0 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 1.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 1.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 1.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.2 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
0.1 | 2.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.6 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 1.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 1.0 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.3 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 1.6 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.3 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 1.0 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.9 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 3.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.1 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
0.0 | 1.0 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.2 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.7 | GO:0032059 | bleb(GO:0032059) |
0.0 | 7.4 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.4 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 0.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 1.8 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 1.2 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 0.6 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.0 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.0 | 4.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 2.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 1.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.4 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.6 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.1 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.0 | 0.5 | GO:0097227 | sperm annulus(GO:0097227) |
0.0 | 0.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.0 | 0.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 1.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.5 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 1.0 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 2.9 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 1.4 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 0.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.5 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 1.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 1.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 1.2 | GO:0016020 | membrane(GO:0016020) |
0.0 | 2.7 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 1.2 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.6 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 2.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 1.7 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.5 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.1 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.1 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 3.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.3 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.0 | 0.3 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 0.8 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 1.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 1.4 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 1.6 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 1.4 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.0 | 1.6 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.2 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.6 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 0.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.7 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.4 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 1.4 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.1 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.3 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 1.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.5 | 2.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.3 | 0.8 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
0.3 | 0.8 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.3 | 1.0 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.3 | 0.8 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.2 | 1.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 5.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.6 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.2 | 1.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.2 | 1.6 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 2.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 0.5 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.2 | 0.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 0.7 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 1.6 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.2 | 0.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.6 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 0.6 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
0.1 | 1.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.4 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 0.8 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.1 | 0.3 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 1.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.3 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
0.1 | 0.8 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.7 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.1 | 0.8 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
0.1 | 0.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 1.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 0.8 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 1.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 1.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 0.7 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 0.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.5 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.2 | GO:0016768 | spermine synthase activity(GO:0016768) |
0.1 | 1.1 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.4 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.1 | 2.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.4 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.1 | 0.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.4 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.1 | 2.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.9 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 1.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 1.7 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 3.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.7 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.2 | GO:0090541 | MIT domain binding(GO:0090541) |
0.1 | 3.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.5 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 2.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 1.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.2 | GO:0031177 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) S-acetyltransferase activity(GO:0016418) phosphopantetheine binding(GO:0031177) |
0.1 | 0.9 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 3.0 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 1.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.2 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.0 | 0.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.0 | 1.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.3 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 2.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 1.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.3 | GO:1901474 | azole transmembrane transporter activity(GO:1901474) |
0.0 | 1.1 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 1.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 1.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 1.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.3 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.0 | 0.3 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.0 | 0.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.0 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.9 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.2 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.0 | 0.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.2 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.0 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.9 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.3 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 0.7 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.0 | 1.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 2.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0031071 | cysteine desulfurase activity(GO:0031071) |
0.0 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.4 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.0 | 1.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 2.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.4 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 1.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.0 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.5 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 1.6 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 1.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.3 | GO:0003712 | transcription cofactor activity(GO:0003712) transcription coactivator activity(GO:0003713) |
0.0 | 0.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.2 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.0 | 1.0 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 1.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 1.3 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 2.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 1.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 1.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.2 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.0 | 0.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.1 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.1 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
0.0 | 1.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.7 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 1.8 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 1.6 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.1 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.0 | 0.1 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.5 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 1.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.3 | GO:0016504 | peptidase activator activity(GO:0016504) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 3.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 3.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 5.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 3.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 1.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 4.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 2.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 2.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 1.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 1.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 1.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 1.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.7 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 1.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 2.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 2.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 1.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 1.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 6.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 2.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.7 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.6 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 1.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 2.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 2.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 1.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 3.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.7 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 1.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 2.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 2.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 1.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 1.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 4.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 1.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 1.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 1.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 1.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 6.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 1.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 2.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 1.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 2.5 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.0 | 1.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.3 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 1.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 2.7 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 1.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.9 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.0 | 3.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 1.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 1.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 1.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.4 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 1.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 4.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |